Search Results - M.I. Gumeniuk

Comorbid Metabolic Disorders in Chronic Lung Diseases by M.I. Gumeniuk

Connect to this object online.

Locking of venous port systems in breaks between infusion cycles: heparinized or normal saline? by M.I. Gumeniuk

Connect to this object online.

Regenerative medicine: going beyond transplantology by M.I. Gumeniuk

Connect to this object online.

Super-infections: does the humankind have weapons to fight? by Y.I. Feshchenko, M.I. Gumeniuk

Connect to this object online.

Anaphylactic shock infusion therapy by M. I. Gumeniuk, G. L. Gumeniuk, S. G. Opimakh

Connect to this object online.

Existing opportunities to increase the effectiveness of tuberculosis Treatment by Y.I. Feshchenko, M.I. Gumeniuk, O.Ya. Korolyuk

Connect to this object online.

Phthisiology questions in International Congress of the European Respiratory Society 2019: achievement of the Ukrainian scientists by M. I. Gumeniuk, G. L. Gumeniuk, D. O. Butov, S. H. Opimakh

Connect to this object online.

Tuberculosis epidemiological situation in Ukraine by Y. I. Feshchenko, V. M. Melnyk, M. I. Gumeniuk, M. I. Lynnyk

Connect to this object online.

Antiviral activity of aminocaproic acid against SARS-CoV-2: review of the literature and results of the first experimental study by J. Chiaravalli, A. Verneuil, V. Osiichuk, D. Golyshkin, O.Ya. Dziublyk, M.I. Gumeniuk, O.S. Denysov

Connect to this object online.

The most significant reasons for the failure of treatment of patients with newly diagnosed pulmonary tuberculosis and possible solutions by M.M. Kuzhko, T.V. Tlustova, D.O. Butov, M.I. Gumeniuk, L.M. Protsyk, A.V. Taranenko

Connect to this object online.

The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia by Y.I. Feshchenko, S. Beridze, Dinh Thi Hoa, V.Y. Molodtsov, M.I. Gumeniuk, N. Gogoreliani, H.I. Sattarov, N. Emukhvari, G. Lupu, Y.M. Mostovoi, L.M. Kuryk, Nguyen Thi Thu Anh

Connect to this object online.

Inhaled antiseptics and inhaled antiviral non-prescription drugs in the prevention of ARVI, in particular COVID-19: an epidemiological study by Yu.I. Feshchenko, M.I. Gumeniuk, М.І. Lynnyk, O.Ya. Dziublyk, M.M. Kuzhko, О.V. Tereshkovych, O.V. Khmel, I.O. Panashchuk, M.V. Yashchenko, О.S. Denysov, Т.А. Sprynsian

Connect to this object online.